Organic Acids
eMolecules 79-14-1 | Glycolic acid | Key Organics/BIONET | MFCD00004312 | 76.051 | C2H4O3 | 95.000 | OCC(O)=O | 50mg | 564178479
Glycolic acid | Key Organics/BIONET | 79-14-1 | MFCD00004312 | 76.051 | C2H4O3 | 95.000 | OCC(O)=O | 50mg | 564178479
eMolecules 79-14-1 | Glycolic acid | Key Organics/BIONET | MFCD00004312 | 76.051 | C2H4O3 | 95.000 | OCC(O)=O | 10mg | 564178478
Glycolic acid | Key Organics/BIONET | 79-14-1 | MFCD00004312 | 76.051 | C2H4O3 | 95.000 | OCC(O)=O | 10mg | 564178478
Medchemexpress LLC Glycolic acid | 79-14-1 | MFCD00004312 | ≥97.0% | 76.05 g/mol | C2H4O3 | 500 MG
Glycolic acid is a small, water-soluble alpha-hydroxy acid used as an analytical reagent and biochemical standard. It acts as a tyrosinase inhibitor and is supplied as a crystalline solid for research and analytical applications; safety, assay, and storage information are provided in the SDS and COA.
- Purity ≥97.0%.
- Molecular weight 76.05 g/mol.
- Chemical formula C2H4O3.
- White to off-white solid.
- Intended for research and analytical use.
- Causes severe skin burns and eye damage; follow SDS handling instructions.
- Store at room temperature; stability data available in COA.
Medchemexpress LLC hsa-miR-6737-3p mimi 5nmol | 5nmol
hsa-miR-6737-3p mimics are small chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity
Medchemexpress LLC Butyric acid-13C4 sodium | 312623-84-0 | 98.0% | 113.06 g/mol | C13C3H7NaO2 | 5mg
Butyric acid-13C4 sodium (Butanoic acid-13C4 sodium) is a stable isotope labeled compound with the activity of promoting cell proliferation and regulating gene expression Butyric acid-13C4 sodium can be used in metabolic research and compound development to help scientists gain a deeper understanding of the role of short-chain fatty acids in organisms Butyric acid-13C4 sodium also plays an important role in nutrition and intestinal health research especially in the regulation of probiotic function and intestinal microbiota
Apexbio Technology LLC Prasugrel hydrochloride 389574-19-0 5mg
Prasugrel hydrochloride (CAS 389574-19-0) is a small molecule inhibitor that targets platelet activation by antagonizing the P2Y12 adenosine diphosphate (ADP) receptor on platelet surfaces By inhibiting this receptor prasugrel impedes ADP-mediated platelet aggregation a critical process in thrombus formation In biochemical assays prasugrel hydrochloride demonstrates an IC50 of 1 8 M for platelet inhibition This compound is utilized in biomedical research to investigate platelet signaling pathways and to model antithrombotic interventions in vitro
Apexbio Technology LLC Prasugrel hydrochloride 389574-19-0 10mM (in 1mL DMSO)
Prasugrel hydrochloride (CAS 389574-19-0) is a small molecule inhibitor that targets platelet activation by antagonizing the P2Y12 adenosine diphosphate (ADP) receptor on platelet surfaces By inhibiting this receptor prasugrel impedes ADP-mediated platelet aggregation a critical process in thrombus formation In biochemical assays prasugrel hydrochloride demonstrates an IC50 of 1 8 M for platelet inhibition This compound is utilized in biomedical research to investigate platelet signaling pathways and to model antithrombotic interventions in vitro
Apexbio Technology LLC Prasugrel hydrochloride 389574-19-0 100mg
Prasugrel hydrochloride (CAS 389574-19-0) is a small molecule inhibitor that targets platelet activation by antagonizing the P2Y12 adenosine diphosphate (ADP) receptor on platelet surfaces By inhibiting this receptor prasugrel impedes ADP-mediated platelet aggregation a critical process in thrombus formation In biochemical assays prasugrel hydrochloride demonstrates an IC50 of 1 8 M for platelet inhibition This compound is utilized in biomedical research to investigate platelet signaling pathways and to model antithrombotic interventions in vitro
Medchemexpress LLC Prasugrel | 150322-43-3 | MFCD09954140 | C20H20FNO3S | 1 ML
Prasugrel is a thienopyridine and proagent that inhibits platelet function. It is an orally active and potent P2Y12 receptor antagonist, inhibiting ADP-induced platelet aggregation.
- Inhibits platelet function
- Orally active
- Potent P2Y12 receptor antagonist
- Inhibits ADP-induced platelet aggregation
- For research use only
Medchemexpress LLC Benzonitrile, 5-[[4-[(6-chlorothieno[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl]methyl]-2-fluoro- | 866206-54-4 | C19H17ClFN5S | 25 MG
PRX-08066 is a selective and orally active 5-hydroxytryptamine receptor 2B (5-HT2BR) antagonist with a Ki of 3.4 nM. It inhibits the MAPK pathway, 5-HT release, and the expression of fibrotic factors. This compound also inhibits the proliferation of KRJ-I cells and induces apoptosis through caspase-3 activation. Additionally, it has been shown to inhibit pulmonary vascular remodeling and is considered for use in pulmonary arterial hypertension (PAH) and neuroendocrine tumors (NET).
- Selective and orally active 5-HT2BR antagonist
- Inhibits MAPK pathway and 5-HT release
- Inhibits expression of fibrotic factors (TGFβ1, CTGF, and FGF2)
- Inhibits proliferation of KRJ-I cells
- Induces apoptosis through caspase-3 activation
- Inhibits pulmonary vascular remodeling
- Potential for use in pulmonary arterial hypertension (PAH)
- Potential for use in neuroendocrine tumors (NET)
Teknova 0.5M Tris -Maleic Acid pH 5.0 Solution. 1000mL, Sterile. 2 pack.
0.5M Tris -Maleic Acid pH 5.0 Solution. 1000mL, Sterile. 2 pack.
